AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...

BeOne Medicines AG posts record Q3 2025 results with 41% revenue growth, BRUKINSA leadership, and major pipeline milestones.

Discover key insights from Iovance Biotherapeutics' Q3 2025 earnings call—including revenue growth, margin gains, and pipeline updates.

DNA isn't just a long string of genetic code, but an intricate 3D structure folded inside each cell. That means the tools ...

Manufacturers everywhere feel they’re behind on mastering their use of operations data. The answer to that problem isn't ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $52.54, along with a high estimate of $78.00 and a low estimate of $23.00. This upward ...

Citizens JMP raised the firm’s price target on Taysha Gene Therapies (TSHA) to $8 from $6 and keeps an Outperform rating on the shares. Taysha ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $336.72, a high ...

Amazon.com's stock has seen its Fair Value Estimate rise from $266.56 to $287.57, driven by increased analyst confidence in the company's outlook. This upward revision is supported by stronger ...

Overview: Data analysis software makes sense of large amounts of information quickly.Tools like R, Python, and SPSS simplify research and statistical studies.Vi ...

As we move into the final stretch of the year, stocks continue to grind higher, with the S&P 500 now up 16% year-to-date.

Robinhood has outperformed the broader market over the past year, and Wall Street analysts are reasonably bullish on its ...